Detalhe da pesquisa
1.
Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective.
Open Heart
; 11(1)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238026
2.
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population.
Pharmacoecon Open
; 8(3): 417-429, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244143
3.
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options.
Patient Prefer Adherence
; 17: 1895-1906, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560147
4.
I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options.
Patient Prefer Adherence
; 17: 1621-1639, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560148
5.
An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective.
Heart Rhythm O2
; 4(9): 528-537, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744940